Kidney fat as a predictor of diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at whether the fat around the kidneys can help predict kidney problems in people with type 2 diabetes. It may help doctors catch kidney damage earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- You are between 18 and 70 years old.
- You do not have cancer or have not had surgery for it.
- You do not have other kidney diseases (besides diabetic kidney disease).
- You are not on dialysis and have not had a kidney transplant.
- You do not have liver cirrhosis, thyroid disease, or insulin-dependent diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special kidney imaging to look for patterns that can predict how diabetic kidney disease may progress. It may help researchers find better ways to identify people at higher risk using noninvasive (and possibly biopsy-related) tests.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
This study looks at how the bacteria in your gut and certain blood markers might help predict changes in blood sugar levels for people with type 2 diabetes and kidney disease. The findings could lead to better ways to manage your condition and prevent complications.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can improve fat tissue health in people with chronic kidney disease who also have type 2 diabetes, cardiovascular disease, or obesity. It may help protect your kidneys and overall health.
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.